Breathe Well Live Well
Condition: Asthma
Interventions: Drug: QMF149; Drug: QMF149; Drug: MF 400; Drug: MF 400; Drug: salmeterol /fluticasone
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Allergic Asthma
Interventions: Biological: ISMIGEN; Biological: PLACEBO
Sponsor: Lallemand Pharma International
Completed – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Persistent Asthma
Interventions: Drug: Beclomethasone Dipropionate; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Elevated Blood Eosinophils
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Lung Disease News |
Evidence of Efficacy of Acupuncture in Children with Asthma Still Missing in …
Lung Disease News Asthma is a frequent inflammatory disease affecting both children and adults, characterized by airway hyper-responsiveness, obstruction, mucus overproduction and remodeling of the airway wall. Globally, this condition affects on average more than 300 … |
View full post on asthma – Google News
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641; Biological: Placebo; Drug: Self-injectable epinephrine; Drug: Albuterol/Salbutamol; Drug: Loratadine; Drug: Olopatadine; Drug: Mometasone furoate monohydrate
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Vilanterol; Drug: Fluticasone propionate; Drug: Salmeterol; Drug: Budesonide; Drug: Formoterol Fumarate
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Placebo; Drug: BI 655066
Sponsor: Boehringer Ingelheim
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Psoriasis
Intervention: Drug: Atorvastatin
Sponsor: Philippine Dermatological Society
Completed – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days